NASDAQ · CVS
Healthcare · Medical - Healthcare Plans
$87.10
Down-$1.24 (-1.42%)
Updated Sep 24, 2026, 1:07 AM
SID Score
4.9/10
Composite research score
Smart Money
60/100
Neutral
Price performance
1M range · 19 trading sessions · Daily adjusted prices
CVS closed at $87.10 after 19 trading sessions, down 7.65% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 22, 2026 | $87.685 | $88.28 | $86.68 | $87.10 | 8.71M |
| Sep 21, 2026 | $88.73 | $88.91 | $87.19 | $87.60 | 10.14M |
| Sep 18, 2026 | $90.09 | $90.48 | $88.15 | $88.84 | 21.88M |
| Sep 17, 2026 | $92.00 | $92.1367 | $90.165 | $90.27 | 7.43M |
| Sep 16, 2026 | $94.46 | $94.95 | $91.44 | $91.72 | 7.24M |
| Sep 15, 2026 | $95.74 | $95.75 | $93.84 | $94.49 | 5M |
| Sep 14, 2026 | $95.44 | $96.01 | $95.28 | $95.55 | 4.45M |
| Sep 11, 2026 | $95.78 | $96.41 | $93.91 | $94.66 | 4.38M |
| Sep 10, 2026 | $96.01 | $97.32 | $94.88 | $95.29 | 3.88M |
| Sep 9, 2026 | $97.39 | $97.98 | $92.7897 | $95.38 | 6.11M |
| Sep 8, 2026 | $95.83 | $96.73 | $95.24 | $96.07 | 4.2M |
| Sep 4, 2026 | $96.59 | $97.69 | $96.285 | $96.74 | 4.5M |
| Sep 3, 2026 | $97.10 | $98.07 | $95.67 | $97.20 | 4.78M |
| Sep 2, 2026 | $97.82 | $98.4999 | $96.90 | $97.23 | 5.4M |
| Sep 1, 2026 | $94.99 | $97.61 | $94.68 | $97.60 | 8.61M |
| Aug 31, 2026 | $93.22 | $94.37 | $92.85 | $93.91 | 10.68M |
| Aug 28, 2026 | $93.40 | $93.93 | $93.01 | $93.06 | 3.99M |
| Aug 27, 2026 | $93.60 | $94.15 | $92.85 | $92.92 | 4.33M |
| Aug 26, 2026 | $93.15 | $94.855 | $92.91 | $94.32 | 6.16M |
The latest Smart Investors Daily articles mentioning CVS.
CVS research
Company profile and research snapshot.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 3, 2026 | UBS | Buy | — |
| Aug 19, 2026 | Argus Research | Buy | — |
| Aug 12, 2026 | JP Morgan | Overweight | — |
| Aug 6, 2026 | Evercore ISI Group | Outperform | — |
| Aug 6, 2026 | UBS | Buy | — |
No generated briefing is available yet.
Yahoo · Sep 18, 2026
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance providers stocks fared in Q2, starting with CVS Health (NYSE:CVS).
Yahoo · Sep 18, 2026
The sale lets Ascension shed insurance risk while Aetna gains a stake in a profitable plan serving high-margin dual-eligible members.
Yahoo · Sep 18, 2026
A piece of the company is winding down its operations under CVS Health.
Yahoo · Sep 18, 2026
Originally published on Company NewsroomThe new mini-pitch brings safe access to play to Orchards Elementary School in Vancouver, WA, as part of 's multi-year field revitalization commitmentNORTHAMPTON, MA AND WOONSOCKET, RI / ACCESS Newswire / September 18, 2026 / ® (NYSE:CVS) announced it has redeveloped a mini soccer pitch in collaboration with Seattle Reign FC and the club's charitable arm, the RAVE Foundation. The mini-pitch, which is located at Orchards Elementary in Vancouver, WA, is now
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CVS.
